Trial intelligence / Profile preview

Pregabalin for chronic central neuropathic pain after spinal cord injury

NCT00407745Phase 3Completed

Sponsor
Viatris
Start
Jan 2007
Primary completion
Feb 2011
Modality
Small Molecules
Countries
10
01

Overview

A Phase 3 trial of pregabalin in central neuropathic pain (CNP), sponsored by Viatris. Started Jan 2007; status: completed.

02

Drugs

pregabalin
03

Conditions

central neuropathic pain (CNP)

Beyond the preview

Go deeper on NCT00407745.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00407745.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call